USA – Trump’s ‘Buy American’ order tasks FDA on essential drugs and devices

President Donald Trump on Thursday signed an executive order aimed at onshoring the production of essential drugs, medical devices and critical inputs for those products to reduce US reliance on foreign manufacturing and promoting federal procurement of domestic goods.
Speaking at a Whirlpool Corporation manufacturing plant in Clyde, Ohio, Trump said the US is too dependent on foreign medicines and supplies. “As we’ve seen in this pandemic, the United States must produce essential equipment, supplies and pharmaceuticals for ourselves,” Trump said.
Industry groups were quick to push back against the order, claiming it could drive up prices and create “chaos” in the pharmaceutical supply chain.
Pharmaceutical Research and Manufacturers of America (PhRMA) President Stephen Ubl said the order, and Trump’s recent executive orders aimed at drug pricing, “contradict and undermine each other.”
“The administration is forcing biopharmaceutical companies to shift their critical attention and resources away from COVID-19 work to focus on making substantial changes to their business models necessary to comply with this and other recent executive orders. Increasing US manufacturing of medicines is a laudable goal, but it cannot happen overnight and should not come at the expense of medical innovation or Americans’ access to the medicines they need,” Ubl said…